Institutional members access full text with Ovid®

Share this article on:

The Efficacy of Retreatment With the Same Medication for Early Treatment Failure of Bacterial Vaginosis

Bunge, Katherine E. MD, MPH*; Beigi, Richard H. MD, MSC*; Meyn, Leslie A. MS; Hillier, Sharon L. PHD*†

doi: 10.1097/OLQ.0b013e3181af6cfd
Note

Few data exist regarding management strategies for women with early treatment failure for bacterial vaginosis. Cure rates after re-treatment were compared for two topical agents. The overall cure rate was 62%; rates between medications were comparable. Re-treatment with the same topical medication for early recurrence is an acceptable strategy.

From the *Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh/Magee-Womens Hospital, Pittsburgh, PA; and †Magee-Womens Research Institute, Pittsburgh, PA.

Supported by an unrestricted research grant from 3M pharmaceuticals and NIH/NIAID U01 AI47785 (CRC MO1 RR00056).

Correspondence: Katherine Bunge, MD, Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Womens Hospital, 300 Halket Street, Pittsburgh, PA 15213. E-mail: kbunge@mail.magee.edu.

Received for publication February 2, 2009, and accepted May 15, 2009.

© Copyright 2009 American Sexually Transmitted Diseases Association